Table 5.
Predictor | AUROC | 95% CI | p-value |
---|---|---|---|
NAFLD | |||
HSI | 0.739 | 0.613–0.865 | 0.002 |
Age, yr | 0.154 | 0.055–0.254 | <0.001 |
Platelet count, ×109/L | 0.886 | 0.793–0.978 | <0.001 |
All HBV | |||
HSI | 0.727 | 0.649–0.805 | <0.001 |
Age, yr | 0.464 | 0.371–0.557 | 0.451 |
Platelet count, ×109/L | 0.733 | 0.658–0.808 | <0.001 |
HBV without AVT | |||
HSI | 0.779 | 0.651–0.907 | 0.001 |
Age, yr | 0.394 | 0.250–0.537 | 0.194 |
Platelet count, ×109/L | 0.679 | 0.538–0.821 | 0.029 |
HBV with AVT | |||
HSI | 0.707 | 0.608–0.805 | 0.001 |
Age, yr | 0.465 | 0.341–0.589 | 0.563 |
Platelet count, ×109/L | 0.744 | 0.652–0.835 | <0.001 |
HSI, hepatic steatosis index; AUROC, area under the receiver operating characteristic curve; CI, confidence interval; NAFLD, nonalcoholic fatty liver disease; HBV, hepatitis B virus; AVT, antiviral therapy.